194 related articles for article (PubMed ID: 26954292)
1. Highly Predictive Model for a Protective Immune Response to the A(H1N1)pdm2009 Influenza Strain after Seasonal Vaccination.
Jürchott K; Schulz AR; Bozzetti C; Pohlmann D; Stervbo U; Warth S; Mälzer JN; Waldner J; Schweiger B; Olek S; Grützkau A; Babel N; Thiel A; Neumann AU
PLoS One; 2016; 11(3):e0150812. PubMed ID: 26954292
[TBL] [Abstract][Full Text] [Related]
2. Relation of activation-induced deaminase (AID) expression with antibody response to A(H1N1)pdm09 vaccination in HIV-1 infected patients.
Cagigi A; Pensieroso S; Ruffin N; Sammicheli S; Thorstensson R; Pan-Hammarström Q; Hejdeman B; Nilsson A; Chiodi F
Vaccine; 2013 Apr; 31(18):2231-7. PubMed ID: 23499520
[TBL] [Abstract][Full Text] [Related]
3. Pandemic influenza A(H1N1)pdm09 improves vaccination routine in subsequent years: a cohort study from 2009 to 2011.
Tacken MA; Jansen B; Mulder J; Visscher S; Heijnen ML; Campbell SM; Braspenning JC
Vaccine; 2013 Jan; 31(6):900-5. PubMed ID: 23246546
[TBL] [Abstract][Full Text] [Related]
4. Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.
Ehrlich HJ; Müller M; Kollaritsch H; Pinl F; Schmitt B; Zeitlinger M; Loew-Baselli A; Kreil TR; Kistner O; Portsmouth D; Fritsch S; Maritsch F; Aichinger G; Pavlova BG; Barrett PN
Vaccine; 2012 Jun; 30(30):4543-51. PubMed ID: 22475864
[TBL] [Abstract][Full Text] [Related]
5. Host immune response to A(H1N1)pdm09 vaccination and infection: a one-year prospective study on six cohorts of subjects.
Liu W; Ma MJ; Tang F; He C; Zhang XA; Jiang LF; Xin DS; Hu CY; Looman C; Cao WC
Vaccine; 2012 Jul; 30(32):4785-9. PubMed ID: 22633868
[TBL] [Abstract][Full Text] [Related]
6. The impact of immunosenescence on humoral immune response variation after influenza A/H1N1 vaccination in older subjects.
Haralambieva IH; Painter SD; Kennedy RB; Ovsyannikova IG; Lambert ND; Goergen KM; Oberg AL; Poland GA
PLoS One; 2015; 10(3):e0122282. PubMed ID: 25816015
[TBL] [Abstract][Full Text] [Related]
7. Distinct patterns of B-cell activation and priming by natural influenza virus infection versus inactivated influenza vaccination.
He XS; Holmes TH; Sanyal M; Albrecht RA; García-Sastre A; Dekker CL; Davis MM; Greenberg HB
J Infect Dis; 2015 Apr; 211(7):1051-9. PubMed ID: 25336731
[TBL] [Abstract][Full Text] [Related]
8. Impacts on influenza A(H1N1)pdm09 infection from cross-protection of seasonal trivalent influenza vaccines and A(H1N1)pdm09 vaccines: systematic review and meta-analyses.
Yin JK; Chow MY; Khandaker G; King C; Richmond P; Heron L; Booy R
Vaccine; 2012 May; 30(21):3209-22. PubMed ID: 22387221
[TBL] [Abstract][Full Text] [Related]
9. CD4+ T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infection.
Schmidt T; Dirks J; Enders M; Gärtner BC; Uhlmann-Schiffler H; Sester U; Sester M
Eur J Immunol; 2012 Jul; 42(7):1755-66. PubMed ID: 22585549
[TBL] [Abstract][Full Text] [Related]
10. HI responses induced by seasonal influenza vaccination are associated with clinical protection and with seroprotection against non-homologous strains.
Luytjes W; Enouf V; Schipper M; Gijzen K; Liu WM; van der Lubben M; Meijer A; van der Werf S; Soethout EC
Vaccine; 2012 Jul; 30(35):5262-9. PubMed ID: 22691431
[TBL] [Abstract][Full Text] [Related]
11. Influenza A(H1N1)pdm09 antibodies after pandemic and trivalent seasonal influenza vaccination as well as natural infection in November 2010 in Hamburg, Germany.
Cramer J; Mac T; Hogan B; Stauga S; Eberhardt S; Wichmann O; Mertens T; Burchard G
Euro Surveill; 2012 Jan; 17(2):. PubMed ID: 22264864
[TBL] [Abstract][Full Text] [Related]
12. Key points in evaluating immunogenicity of pandemic influenza vaccines: A lesson from immunogenicity studies of influenza A(H1N1)pdm09 vaccine.
Ohfuji S; Kobayashi M; Ide Y; Egawa Y; Saito T; Kondo K; Ito K; Kase T; Maeda A; Fukushima W; Hirota Y
Vaccine; 2017 Sep; 35(39):5303-5308. PubMed ID: 28784284
[TBL] [Abstract][Full Text] [Related]
13. Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine.
Tete SM; Jul-Larsen Å; Rostami S; Lunde THF; Søland H; Krammer F; Cox RJ
Vaccine; 2018 Apr; 36(16):2213-2219. PubMed ID: 29548607
[TBL] [Abstract][Full Text] [Related]
14. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.
Hsu JP; Phoon MC; Koh GC; Chen MI; Lee VJ; Wu Y; Xie ML; Cheong A; Leo YS; Chow VT
Int J Infect Dis; 2012 Aug; 16(8):e621-7. PubMed ID: 22704721
[TBL] [Abstract][Full Text] [Related]
15. Seasonal FluMist vaccination induces cross-reactive T cell immunity against H1N1 (2009) influenza and secondary bacterial infections.
Sun K; Ye J; Perez DR; Metzger DW
J Immunol; 2011 Jan; 186(2):987-93. PubMed ID: 21160043
[TBL] [Abstract][Full Text] [Related]
16. Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children.
Örtqvist Å; Bennet R; Hamrin J; Rinder MR; Lindblad H; Öhd JN; Eriksson M
Vaccine; 2015 May; 33(22):2558-61. PubMed ID: 25869891
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of monovalent 2009 pandemic influenza A virus subtype H1N1 and 2010-2011 trivalent inactivated influenza vaccines in Wisconsin during the 2010-2011 influenza season.
Bateman AC; Kieke BA; Irving SA; Meece JK; Shay DK; Belongia EA
J Infect Dis; 2013 Apr; 207(8):1262-9. PubMed ID: 23341536
[TBL] [Abstract][Full Text] [Related]
18. Early Rise of Blood T Follicular Helper Cell Subsets and Baseline Immunity as Predictors of Persisting Late Functional Antibody Responses to Vaccination in Humans.
Spensieri F; Siena E; Borgogni E; Zedda L; Cantisani R; Chiappini N; Schiavetti F; Rosa D; Castellino F; Montomoli E; Bodinham CL; Lewis DJ; Medini D; Bertholet S; Del Giudice G
PLoS One; 2016; 11(6):e0157066. PubMed ID: 27336786
[TBL] [Abstract][Full Text] [Related]
19. Low expression of activation marker CD69 and chemokine receptors CCR5 and CXCR3 on memory T cells after 2009 H1N1 influenza A antigen stimulation in vitro following H1N1 vaccination of HIV-infected individuals.
Chawansuntati K; Chotirosniramit N; Sugandhavesa P; Aurpibul L; Thetket S; Kosashunhanan N; Supindham T; Kaewthip O; Sroysuwan P; Sirisanthana T; Suparatpinyo K; Wipasa J
Hum Vaccin Immunother; 2015; 11(9):2253-65. PubMed ID: 26091502
[TBL] [Abstract][Full Text] [Related]
20. Antibody persistence and response to 2010-2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children.
Gilca V; De Serres G; Hamelin ME; Boivin G; Ouakki M; Boulianne N; Sauvageau C; Dionne M; Gilca R; Skowronski D
Vaccine; 2011 Dec; 30(1):35-41. PubMed ID: 22063386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
